Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00823134
Other study ID # D2231-109
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2008
Est. completion date March 2009

Study information

Verified date March 2020
Source ResMed
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the following topics:

- Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas.

- Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to the 2008 guidelines of the AASM = American Academy of Sleep Medcine.

- Determine whether patients can start and stop the recorder and are able to attach the additional effort sensor by themselves using the patient instruction sheet


Description:

- Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas.

- Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to the 2008 guidelines of the AASM = American Academy of Sleep Medcine.

- Determine whether patients can start and stop the recorder and are able to attach the additional effort sensor by themselves using the patient instruction sheet


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Willing to give written informed consent

- Adult patients who are 18 years of age or older

- No alcohol consumption 12 hrs before and during the trial period

- Normally sleep more than 3 hours per night

Exclusion Criteria:

- Unable to comprehend written and spoken German.

- Pregnant

- Patients who use of Bilevel PAP or CPAP therapy during the PSG

- Unsuitable for inclusion in the opinion of the investigator

Study Design


Intervention

Device:
ApneaLink Plus
Device used to evaluate for the presence of obstructive, central or mixed apneas

Locations

Country Name City State
Germany Medizinische Klinik für Atemwegserkrankungen und Allergien, Fachkliniken Wangen Wangen Im Allgäu Baden-Württemberg

Sponsors (1)

Lead Sponsor Collaborator
ResMed

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation Period Apnoea is defined as a decrease in flow of =90% from baseline for at least 10 seconds; hypopnea is a decrease in flow =30% from baseline for at least 10 seconds and an oxygen desaturation of =4%; obstructive: breathing efforts are ongoing; central: no breathing efforts one night
Primary Correlation Coefficient of Apnoea-Hypopnea-Index (AHI) (PSG) - AHI (AL) The AHI (PSG) values and AHI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
Primary Correlation Coefficient of Apnoea-Index (AI) (PSG) - AI (AL) The AI (PSG) values and AI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
Primary Correlation Coefficient of Obstructive-Apnoea-Index (OAI) (PSG) - OAI (AL) The OAI (PSG) values and OAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
Primary Correlation Coefficient of Central-Apnoea-Index (CAI) (PSG) - CAI (AL) The CAI (PSG) values and CAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
Primary Correlation Coefficient of Apnoea-Index (HI) (PSG) - HI (AL) The HI (PSG) values and HI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
Primary Correlation Coefficient of Obstructive-Apnoea-Index (ODI) (PSG) - ODI (AL) The ODI (PSG) values and ODI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of >75% will be seen as threshold for validity. 1 night
See also
  Status Clinical Trial Phase
Terminated NCT03605329 - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS N/A
Completed NCT04912635 - Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo N/A
Not yet recruiting NCT05939934 - Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal N/A
Enrolling by invitation NCT02290236 - Monitored Saturation Post-ICU N/A
Terminated NCT02269774 - Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea N/A
Completed NCT02088723 - Testing the Elevation as Sleep Apnea Treatment N/A
Completed NCT02261857 - 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea Early Phase 1
Completed NCT01181570 - Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea Phase 4
Completed NCT01943708 - Novel Auto-continuous Positive Airway Pressure (CPAP) Validation Phase 3
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT02166879 - Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
Recruiting NCT04963192 - Integrated Management of Chronic Respiratory Diseases N/A
Completed NCT05056766 - How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
Completed NCT04846400 - Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia N/A
Recruiting NCT04314492 - Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults N/A
Completed NCT05175287 - OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
Active, not recruiting NCT03431038 - Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH N/A
Enrolling by invitation NCT03075787 - Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea N/A
Completed NCT03300037 - HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor N/A
Recruiting NCT06097949 - AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy